Study S000730

A Pilot Study to Estimate Early Clinical Efficacy Signals of a Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Administration in Conjunction With Levonorgestrel Intrauterine Device (LNG-IUD) in Obese Patients With Endometrioid Intraepithelial Neoplasia

ClinicalTrials.gov record

Registration

Registration: NCT07107334
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 20
Start: 2026-04-07
Primary completion: 2028-11
Lead sponsor: University of Florida
Conditions: Endometrioid Endometrial Adenocarcinoma
Interventions: DRUG:Glucagon-like peptide 1 receptor agonist
Results posted: FALSE

Registered primary outcomes

Time from start of GLP-1RA to clearance of staging hysterectomy [12 months]
Time from start of GLP-1RA to clearance for pregnancy pursuit [12 months]
Endometrial pathologic response [6 months after beginning GLP-1RA treatment]
Endometrial pathologic response [12 months after beginning GLP-1RA treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.